Document is current
Any future updates will be listed below
-
Authors
Mejia, Alan Castro
Sapienza, Stefano https://orcid.org/0000-0002-0917-6454
Paccoud, Ivana
Alcock, Lisa
Brown, Philip
Gaßner, Heiko
Hunter, Heather
Maetzler, Walter
Mirelman, Anat
Nieuwboer, Alice
Regensburger, Martin
Rochester, Lynn
Stallforth, Sabine
Vereijken, Beatrix
Yarnall, Alison
Klucken, Jochen
-
Funding
Funding for this research was provided by:
Fonds National de la Recherche Luxembourg (17981757, 14146272)
Innovative Medicines Initiative (820820)
NIHR Newcastle Biomedical Research Centre (2020-2024; 2024-2028, 2020-2024; 2024-2028, 2020-2024; 2024-2028)
Deutsche Forschungsgemeinschaft (442419336, 438496663)
Fraunhofer Internal Programs (044-602140, 044-602150, SME 40-09311)
- License Information
-
More Information
Article History
Received: 14 May 2025
Accepted: 2 September 2025
First Online: 18 September 2025
Declarations
:
: Ethical approval was not required for this study as it did not involve research on human participants. The consensus offered contributions to the research topic where expert opinions were voluntary.
: Not applicable.
: ACM, SS, IP, BV, MR, LR, PB, AN, AY, SST, HG, HH, WM, and AM declare no competing interests. LA reports consultancy activity with Hoffmann-La Roche Ltd. outside of this study. JK acknowledges shares in Portabiles HCT GmbH, manufacturer of the gait sensor system providing digital mobility outcomes. The companies did not influence the study, nor and the outcomes of the study.
